Spots Global Cancer Trial Database for individual patient tcr transduced pbl
Every month we try and update this database with for individual patient tcr transduced pbl cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab | NCT04135092 | Individual Pati... Cyclophosphamid... Fludarabine Aldesleukin Pembrolizumab | - | National Institutes of Health Clinical Center (CC) |